Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
- Name
- Vascular Endothelial Growth Factor Receptor-2, antagonists & inhibitors
- Accession Number
- DBCAT001653
- Description
Not Available
- Drugs
Drug Drug Description Pegdinetanib Investigated for use/treatment in cancer/tumors (unspecified) and macular degeneration. Tesevatinib Tesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs... Golvatinib Golvatinib has been investigated for the treatment of Platinum-Resistant Squamous Cell Carcinoma of the Head and Neck. - Drugs & Drug Targets